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Summary This report describes the development of a 
method to measure mRNA in small samples of human tissue 
by the polymerase chain reaction with a nonradioactive 
label. In this method RNA is reverse-transcribed in the 
presence of a control RNA, and subsequently amplified by 
the polymerase chain reaction during which a nonradioac- 
tive label (digoxigenin-1 1dUTP) is incorporated. Gel blot- 
ting and immunological detection of digoxigenin followed 
by a chemiluminescent reaction provide an intense signal on 
film. This allows the detection and quantitation of 3- 
hydroxy-3methylglutaryl (HMG) CoA reductase mRNA in 
12 ng of RNA. We demonstrate that this is a sensitive and 
reproducible method, and that quantitation is linear with 
respect to the amount of mRNA present. The application of 
this method to the measurement of low density lipoprotein 
receptor and 3-hydroxy-3methylglutaryl coenzyme A reduc- 
tase mRNA levels in circulating peripheral blood 
mononuclear cells and human liver biopsy samples is dis- 
cussed. The use of chemiluminescent reagents instead 
of radioactive labels allows this procedure to be performed 
safely in laboratories not equipped for radioactivity.- 
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The key regulatory steps in the cellular pathway for 
cholesterol metabolism involve the rate-limiting en- 
zyme for cholesterol biosynthesis, 3-hydroxy-%methyl- 
glutaryl coenzyme A reductase (HMG-CoA reductase), 
and the receptor-mediated endocytosis of low density 
lipoproteins (LDL) by the LDL receptor (LDL-R) (1). 
Knowledge of the way in which these genes are regu- 
lated is of vital importance, not only for an under- 
standing of lipoprotein and cholesterol metabolism, 
but also for delineating new ways to influence plasma 
LDL-cholesterol levels and thus interfere with the 
process of atherogenesis. A major difficulty in studying 
the regulation of HMGCoA reductase and LDL-R 
gene expression in humans in vivo has been the 
limited amount of tissue available for RNA analysis. 
Conventional methods of mRNA analysis such as 
Northern and dot-blot hybridization and nuclease 
protection analysis are often not sensitive enough to 
detect rare mRNA species in samples limited by size 
(2, 3). In a study of lymphocyte LDLR gene regula- 
tion using the nuclease protection method, small 
amounts of LDLR mRNA were detected, but this re- 
quired 10 pg of total RNA (4). The polymerase chain 
reaction (PCR) has become an invaluable tool for the 
study of low-copy number mRNA transcripts, but in 
most cases has provided only qualitative results. 
Recently Wang, Doyle, and Mark (5) have described a 
method for the quantitation of specific mRNA species 
by PCR using a synthetic RNA as an internal standard. 
This approach involves coamplification of a target 
mRNA with a synthetic RNA that utilizes the same 
primer sequences but yields a PCR product of a dif- 
ferent size. However, the use of high specific activity 
radioisotopes as a label in these PCR reactions remains 
problematical. In addition to concerns about safety, 
32P-labeled primers and PCR products have a short 
half-life. We have adapted the method of Wang et al. 
(5) by the incorporation of a nonradioactive label 
during amplification followed by detection and quan- 
titation using chemiluminescence (6, 7). In this re- 
port, we de'scribe the application of this method to the 
measurement of LDL-R and HMGCoA reductase 
mRNA levels in circulating peripheral blood mono- 
nuclear (PBMN) cells and human liver biopsy samples. 
We suggest that this technique may be useful in clini- 
cal laboratories for the quantitative analysis of gene ex- 
pression in the small tissue samples available from in 
vivo sources. 
MATERIALS AND METHODS 
RNA preparation 
Total cellular RNA was prepared from lymphocytes 
in 10 ml venous blood samples and from 5- to 10-mm 
needle liver biopsies obtained from patients who had 
undergone cholecystectomy for gallstones. The basic 
procedure of Chirgwin et al. (8) and Glisin, Crkven- 
jakov, and Byus (9) was used. After homogenization in 
1.2 ml guanidinium solution (4 M guanidinium isothio- 
cyanate, 20 mM sodium acetate, pH 5.2, 0.1 mM di- 
thiothreitol, 0.5% N-lauryl sarcosine) the lysates were 
layered over a I-ml 5.7 M cesium chloride cushion and 
spun in a TLS-55 Rotor at 33,000 rpm in a TLlOO 
centrifuge (Beckman) for 15-18 h. The PBMN cell 
RNA pellets were resuspended in 90 p1 TES buffer (10 
mM Tris-HC1, pH 7.4,5 mM EDTA, 1% sodium dodecyl 
sulfate), precipitated twice with 0.1 vol 3 M sodium 
acetate/2.5 vol ethanol, and finally resuspended in 10 
p1 of sterile deionized water. The liver RNA pellets 
were resuspended in 200 pl TES buffer, extracted with 
phenol-chloroform-isoamyl alcohol 1 :0.95:0.05 (v/v) , 
then with chloroform-isoamyl alcohol 0.95:0.05 (v/v) 
and finally resuspended in 10 p1 of sterile deionized 
water. The RNA concentration was measured 
spectrophotometrically at 260 nm. 
PCR ampiification with a nonradioactive label 
Aliquots of total cellular RNA were reverse- 
transcribed into cDNA along with lo4 molecules of 
Awl09 cRNA. This cRNA is available commercially 
from Perkin-Elmer Cetus. Awl09 contains primer sites 
for a number of cytokines, apolipoprotein E and lipo- 
protein lipase, in addition to the LDLR and HMG 
CoA reductase. A 20-p1 reverse transcription reaction 
mixture containing up to 120 ng of total cellular RNA, 
lo4 molecules of Awl09 cRNA, 1 x PCR buffer (10 mM 
Tris-HC1, pH 8.3, 50 mM KCl, 2.5 mM MgCl*), 20 units 
of RNasin (Cetus), 2.5 pM random hexanucleotide 
Abbreviations: AMPPD, disodium 3(4methoxyspiro[ l,2dioxe- 
tane-3,2'tricyclo[3.3.1. l"'] decanl-4yl)phenyl phosphate; HMGCoA 
reductase, %hydroxy-3methylglutaryl coenzyme A reductase; LDL 
R, low density lipoprotein receptor; PCR, polymerase chain reac- 
tion; PBMN cells, peripheral blood mononuclear cells; DIG, 
digoxigenin-1 1dUTP. 
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primers (Cetus), 1 mM each dGTP, dATP, and dCTP, 
0.975 mM dTTP (Boehringer Mannheim), and 50 
units of Moloney Murine Leukemia Virus reverse 
transcriptase (Cetus) was incubated at room tempera- 
ture for 10 min, 42°C for 15 min, 95°C for 5 min, and 
then quickchilled on ice. Digoxigenin-1 1-dUTP (DIG) 
(Boehringer Mannheim) was incorporated as a non- 
radioactive label during PCR amplification of the 
reverse-transcribed RNA. A DIG concentration in the 
PCR mix of 50 p~ was recommended by the manufac- 
turer. To reduce the cost of this reagent, we have suc- 
cessfully reduced the concentration of DIG down to 14 
pM. In the current experiments, PCR was performed at 
a final concentration of 1 x PCR buffer, 1.25 units of 
T h m u s  aquaticus DNA polymerase (Perkin-Elmer/ 
Cetus), 14-25 p~ DIG, with the addition of 10 p1 of 
reverse transcription reaction mixture in a total of 50 
pl. A total of 15 pmol each of 5’ and 3’ LDL-R or HMG 
primers was added to the PCR mixture. The primer se- 
quences are shown in Table 1. The mixture was over- 
laid with 20 p1 of Nujol mineral oil (Cetus) and then 
amplified with a Bioquest thermal cycler. The 
amplification profile involved denaturation at 95°C for 
30 sec, primer annealing at 55°C for 30 sec, and exten- 
sion at 72°C for 1 min. 
PCR product detection by chemiluminescence 
Ten p1 of each PCR reaction mixture was 
electrophoresed in a minigel apparatus at 9OV for 90 
min in 3% agarose (Pharmacia) gels (10 cm x 7 cm) in 
Tris-borate/EDTA buffer, to allow adequate separation 
of the target and synthetic amplification products. The 
DNA was transferred to a nylon membrane (Boeh- 
ringer Mannheim) by blotting for 3 h in 10 x SSC (20 
X SSC: 3 M sodium chloride, 0.3 M sodium citrate, pH 
7). The blot was baked under vacuum at 120°C for 20 
min and rinsed in 2xSSC. Detection of the PCR 
products was performed directly on the nylon 
membrane. The blot was washed briefly in buffer A 
(maleic acid, 0.1 M; sodium chloride 0.15 M, pH 7.5, 
plus Tween 20, 0.3%) and incubated for 30 min at 
room temperature in blocking buffer (1% blocking 
reagent (Boehringer Mannheim) in buffer A). This 
was followed by a 30-min incubation with an an- 
tidigoxigenin-IgG conjugated to alkaline phosphatase 
(Boehringer Mannheim) diluted 1 in lo4 in blocking 
buffer. The blot was then washed twice for 15 min in 
buffer A and incubated in buffer B (Tris-HC1, 0.1 M; 
sodium chloride, 0.1 M; magnesium chloride, 50 mM, 
pH 9.5) for 5 min. Chemiluminescent detection was 
performed by incubating the membrane for 5 min in a 
solution of AMPPD (100 pg/ml in buffer B). The 
diluted substrate solution can be stored at 4°C and 
reused at least six times. The membrane was blotted 
lightly and sealed in a clear plastic bag. Exposure to 
X-ray film (Agfa Curix MR4) was performed in an X- 
ray cassette at room temperature. Sharp distinct sig- 
nals corresponding to the target mRNA and the 
synthetic internal control were obtained without back- 
ground signals within 2-10 min. Typically, several ex- 
posures were made for the same blot to ensure that 
band intensities were within an appropriate range for 
densitometric analysis (see below). 
Quantitation 
Each pair of signals corresponding to the target 
mRNA and the internal control was scanned by a laser 
densitometer (Helena Laboratories, Rapid Electro- 
phoresis Analyzer). Quantitation of the target mRNA 
was performed by comparison with the cRNA internal 
standard, and expressed per pg of total cellular RNA. 
Analysis was generally limited to exposures that gave 
absorbance readings of < 1.0 for individual bands. In- 
tegration of peak areas was performed using programs 
provided with the densitometer. The concentration of 
LDL-R or HMGCoA reductase mRNA was calculated 
from the relative sample and control peak areas(R) 
and the known number of molecules of cRNA added 
to the PCR reaction: 
R x (copies of cRNA added) 
(pg of human RNA added ). 
mRNA molecules/pg RNA = 
RESULTS AND DISCUSSION 
Reverse transcription and coamplification of syn- 
thetic cRNA and human RNA corrects for variables 
TABLE 1 .  Primer sequences for amDlification of human and svnthetic RNA 
mRNA 
Species 5’ Primers 
~ 
Size of PCR 
Product 
3’ Primers mRNA cRNA 
base pairs 
LDLR 5’-CAATGTCTCACCAAGCTCTGY 5’-TCTGTCTCGAGGGGTAGCTGY 258 30 1 
HMG 5’-TACCATGTCAGGGGTACGTC-3’ 5’-CAAGCCTAGAGACATAATCATC-3’ 246 303 
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due to differences in sample preparation, conditions 
of reverse transcription, and PCR amplification. Since 
the same primers are used in the PCR amplification of 
both templates, there are no differences in primer ef- 
ficiency for cDNA derived from cRNA or mRNA. Fig. 
1A illustrates the chemiluminescent image obtained 
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Dis tance  
Fq. 1. Chemiluminescent images and  densitometric scans of PCR 
amplified cRNA and mRNA. A Chemiluminescent image. RNA iso- 
lated from PBMN cells was reverse-transcribed in the presence of 
IO4 copies of Awl09 cRNA and subjected to 25 cycles of PCR 
amplification with LDLR or HMCCoA reductase primers. PCR 
products were separated by agarose gel electrophoresis, blotted 
onto a nylon membrane and detected by chemiluminescence as 
described in Materials and Methods. Lane 1: PCR with LDLR 
primers; lane 2 PCR with HMCCoA reductase primers. The  upper 
band in each case corresponds to cRNA and the lower band to the 
specific mRNA. B Densitometric scans of the chemiluminescent im- 
ages in A. Digitized densitometric scans (0) were analyzed using a 
nonlinear cuwe-fitting algorithm (Peakft, Jandel Scientific), In- 
dividual peaks (.......) and the summation of these peaks (-) 
are shown. 
on X-ray film From PCR-amplified cRNA and mRNA 
separated on an agarose gel and transferred to a nylon 
filter. These data demonstrate the sensitivity of 
chemiluminescence as a detection method for PCR 
products. The direct incorporation of DIGlabeled 
dUTP makes it possible to compare the relative inten- 
sities of the cRNA and mRNA bands to calculate a b  
solute copy numbers of specific mRNAs. Densitometric 
scans of cRNA and mRNA bands shown in Fig. 1B 
demonstrate that the band separation is adequate to 
allow quantitation of relative areas. The result of an 
analysis by nonlinear curve fitting (Peakfit, Jandel 
Scientific) is shown and demonstrates that the scans 
can be fitted to two individual peaks. 
To assess the utility of DIGPCR as a quantitative 
method, we addressed the following questions: i) is 
quantitation affected by the number of PCR cycles; ii) 
is quantitation linear with respect to the amount of 
mRNA present; and iii) is the method reproducible. 
The first question is important because the efficiency 
of PCR amplification decreases at high cycle numbers 
(10). As a result, the number of cycles in quantitative 
PCR reactions is usually limited to keep amplification 
exponential. To determine whether the cycle number 
affected the ratio of PCR products formed, 120 ng of 
total PBMN cell RNA and lo4 copies of Awl09 cRNA 
were subjected to 24, 26, 28, or 30 cycles of amplifica- 
tion using the LDLR specific primers. The intensity of 
the resulting chemiluminescent bands increased 
markedly for both templates between 24 and 28 cycles 
and then leveled off. The amount of target mRNA at 
each cycle number was calculated from appropriate X- 
ray film exposures and is summarized in Table 2. 
These data show that the ratios between the mRNA 
and cRNA band intensities and the calculated LDLR 
mRNA copy number vary little between 24 and 28 
cycles. Even at 30 cycles, when the amplification ef- 
ficiency has leveled off dramatically, the calculated 
copy number remains similar. We surmise that the use 
of identical primers for both PCR products is respon- 
sible for the insensitivity to the number of cycles. For 
subsequent reactions reported here we have used 25 
cycles. Clearly, if substantially smaller amounts of RNA 
TABLE 2. Effect of increasing number of PCR cycles on  the rela- 
rive intensity of the cRNA and mRNA bands and the 
calculated mRNA copy number 
PCR Bands Pcr Pg RNA 
Number of Cycles Relative Intensity of mRNA Copy Number x I@ 
cRNA mRNA 
24 
26 
28 
30 
17.1 79.4 23.2 
16.4 83.6 25.5 
16.1 83.9 26.1 
18.9 81.1 21.5 
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are used, the number of cycles could be increased 
without a significant loss in accuracy. 
To demonstrate that the DIGPCR method is linear 
with respect to the amount of target mRNA, we per- 
formed a series of experiments in which lo4 molecules 
of Awl09 cRNA were combined with either 6 ng, 9 ng, 
12 ng, 15 ng, 21 ng, or 24 ng of human total liver 
RNA. After reverse transcription, PCR amplification 
was performed with HMGCoA reductase-specific 
primers for 25 cycles and the products were analyzed 
by chemiluminescence and densitometry. The results 
shown in Fig. 2 illustrate that the intensity of the 
mRNA band is directly proportional to the amount of 
RNA used for reverse transcription and PCR amplifica- 
tion. This fulfills an essential requirement for the 
detection of variable amounts of mRNA in RNA 
preparations. 
To assess the reproducibility of the DIGPCR 
method, two separate lymphocyte and RNA samples 
were prepared from 20 ml of fasting venous blood and 
analyzed separately for HMGCoA reductase and LDL 
R mRNA content. The results, summarized in Table 3, 
show that the two measured LDL-R and HMG-CoA 
reductase mRNA levels varied by 13% and 2%, respec- 
tively. In a separate study of ten patients, the variation 
between duplicate measurements of HMGCoA reduc- 
tase and LDL-R mRNA levels was found to be 30%. 
For more precise measurements, a range of RNA con- 
centrations was used and the results were calculated by 
a least squares analysis of the data as shown in Fig. 2. 
Copy numbers in this study were found to fall within 
Liver RNA (ng) 
Fig. 2. Relationship of intensity of mRNA band to amount of RNA 
used for reverse transcription and PCR amplification. One x lo4 
molecules of Awl09 cRNA were combined with either 6 ng, 9 ng, 
12 ng, 15 ng, 21 ng, or 24 ng of human total liver RNA. After 
reverse transcription, PCR amplification was performed with H M G  
CoA reductase specific primers for 25 cycles and the products were 
analyzed by chemiluminescence and densitometry. 
TABLE 3. Specific mRNA levels in two separate lymphocyte and 
RNA preparations from one blood sample 
Sample mRNA Copies X lo4& RNA 
LDLR HMG 
RNA- 1 12.5 81.9 
RNA-2 14.2 83.7 
quite a narrow range, varying between 7 and 35 x lo4 
copies for LDLR mRNA and 5 and 22 x 105 copies for 
HMG-CoA reductase mRNA. Using similar PCR tech- 
nology, Wang et al. (5) have calculated that there are 
1.3 x lo4 copies of LDLR mRNA in a normal human 
coronary artery. 
The above experiments have shown that mRNA can 
be quantitated by DIGPCR with the use of an internal 
cRNA standard. The incorporation of DIG as a label 
during amplification allowed direct comparison of the 
final PCR products. The use of this nonradioactive 
label has a number of distinct advantages. The detec- 
tion process is rapid and safe, eliminating the need for 
radioactivity or generation of probes. The newer 
chemiluminescent substrates such as AMPPD markedly 
enhance the sensitivity of detection. No  background 
staining was observed during the brief X-ray film ex- 
posures (<lo min) required to produce strong signals. 
The high intensity of the emitted blue light also en- 
sures that the response of film, which has not been 
preflashed, is linear to incoming light ( 1 1 ) .  The 
labeled PCR products can be stored indefinitely for 
use as controls or comparison in subsequent experi- 
ments, in contrast to 32P-labeled primers which have a 
short half-life. 
This method of quantitative PCR with a nonradioac- 
tive label has important implications for the study of 
human pathology in clinical laboratories. The meas- 
urement of a number of specific mRNA molecules can 
be readily performed in small samples of human tissue 
such as that obtained by liver biopsy. Replacement of 
radioactive labels by chemiluminescent reagents allows 
this procedure to be performed safely in laboratories 
not equipped for radioactivity. The ease and rapidity 
of the detection method makes it possible to process 
samples quickly and it may thus be used to follow 
changes in the expression of specific RNA molecules, 
for example during treatment of metabolic disorders. 
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